Occurrence of fluoroquinolones and fluoroquinolone-resistance genes in the aquatic environment

Science of the Total Environment

Volumn 444, Issue , 2013, Pages 508-514

  Adachi, Fumie ^a   Yamamoto, Atsushi ^b   Takakura, Koh Ichi ^b   Kawahara, Ryuji ^a  

^a OSAKA PREFECTURAL INSTITUTE OF PUBLIC HEALTH   (Japan)

^b OSAKA CITY INSTITUTE OF PUBLIC HEALTH AND ENVIRONMENTAL SCIENCES   (Japan)

Author keywords

Escherichia coli; Fluoroquinolones; LC MS MS; Mutations; Plasmid mediated quinolone resistance; PPCPs

Indexed keywords

ANTIBIOTICS; ANTIMICROBIAL AGENTS; DNA; GENE TRANSFER; GENES;

AQUATIC ENVIRONMENTS; FLUOROQUINOLONES; LC-MS-MS; LC.MS/MS; MUTATION; NALIDIXIC ACID; OFLOXACIN; PLASMID-MEDIATED QUINOLONE RESISTANCE; PPCP; QUINOLONES;

ESCHERICHIA COLI;

CIPROFLOXACIN; DNA TOPOISOMERASE (ATP HYDROLYSING) A; ENOXACIN; ENROFLOXACIN; NALIDIXIC ACID; NORFLOXACIN; OFLOXACIN; PROTEIN PARC; PROTEIN PARE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

AMINO ACID; ANTIMICROBIAL ACTIVITY; AQUATIC ENVIRONMENT; BACTERIUM; CONCENTRATION (COMPOSITION); CORRELATION; GENE; GENOTYPE; PHENOTYPE; PLASMID; POLLUTION EXPOSURE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; AQUATIC ENVIRONMENT; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM DETECTION; BACTERIUM ISOLATION; ESCHERICHIA COLI; GENE AMPLIFICATION; GENETIC ANALYSIS; GENOTYPE; JAPAN; LIMIT OF DETECTION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; QNR GENE; SANITATION; WATER SAMPLING;

HONSHU; JAPAN; KINKI; OSAKA [KINKI];

ESCHERICHIA COLI;

EID: 84871997055     PISSN: 00489697     EISSN: 18791026     Source Type: Journal    
DOI: 10.1016/j.scitotenv.2012.11.077     Document Type: Article

References (50)

1. Akaike H. A new look at the statistical model identification. IEEE Trans Autom Control 1974, 19:716-723.
2. Allen H.K., Donato J., Wang H.H., Cloud-Hansen K.A., Davies J., Handelsman J. Call of the wild: antibiotic resistance genes in natural environments. Nat Rev Microbiol 2010, 8:251-259.
3. Batt A.L., Bruce Ian B., Aga D.S. Evaluating the vulnerability of surface waters to antibiotic contamination from varying wastewater treatment plant discharges. Environ Pollut 2006, 142:295-302.
4. Carballa M., Omil F., Lema J.M., Llompart M., García C., Rodriguez I., et al. Behaviour of pharmaceuticals and personal care products in a sewage treatment plant of northwest Spain. Water Sci Technol 2005, 52:29-35.
5. Cattoir V., Poirel L., Rotimi V., Soussy C.J., Nordmann P. Multiplex PCR for detection of plasmid-mediated quinolone resistance qnr genes in ESBL-producing enterobacterial isolates. J Antimicrob Chemother 2007, 60:394-397.
6. Cattoir V., Poirel L., Aubert C., Soussy C.J., Nordmann P. Unexpected occurrence of plasmid-mediated quinolone resistance determinants in environmental Aeromonas spp. Emerg Infect Dis 2008, 14:231-237.
7. Clinical and Laboratory Standard Institute (CLSI) Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals. CLSI document M31-A3 2008, CLSI, Wayne, PA. Third edition.
8. Courvalin P. Plasmid-mediated 4-quinolone resistance: a real or apparent absence?. Antimicrob Agents Chemother 1990, 34:681-684.
9. Dutta S., Kawamura Y., Ezaki T., Nair G.B., Iida K., Yoshida S. Alteration in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV in quinolone-resistant Shigella dysenteriae serotype 1 clinical isolates from Kolkata, India. Antimicrob Agents Chemother 2005, 49:1660-1661.
10. Fernández C., González-Doncel M., Pro J., Carbonell G., Tarazona J.V. Occurrence of pharmaceutically active compounds in surface waters of the Henares-Jarama-Tajo River system (Madrid, Spain) and a potential risk characterization. Sci Total Environ 2010, 408:543-551.
11. Ferrer I., Zweigenbaum J.A., Thurman E.M. Analysis of 70 environmental protection agency priority pharmaceuticals in water by EPA method 1694. J Chromatogr A 2010, 1217:5674-5686.
12. Fick J., Söderström H., Lindberg R.H., Phan C., Tysklind M., Joakim, et al. Contamination of surface, ground, and drinking water from pharmaceutical production. Environ Toxicol Chem 2009, 28:2522-2527.
13. Gros M., Petrović M., Barceló D. Tracing pharmaceutical residues of different therapeutic classes in environmental waters by using liquid chromatography/quadrupole-linear ion trap mass spectrometry and automated library searching. Anal Chem 2009, 81:898-912.
14. Hooper D.C. Emerging mechanisms of fluoroquinolone resistance. Emerg Infect Dis 2001, 7:337-341.
15. Hopkins K.L., Day M., Threlfall E.J. Plasmid-mediated quinolone resistance in Salmonella enterica, United Kingdom. Emerg Infect Dis 2008, 14:340-342.
16. Jakobsen L., Sandvang D., Hansen L.H., Bagger-Skjøt L., Westh H., Jørgensen C., et al. Characterisation, dissemination and persistence of gentamicin resistant Escherichia coli from a Danish university hospital to the waste water environment. Environ Int 2008, 34:108-115.
17. Kim H.B., Park C.H., Kim C.J., Kim E.C., Jacoby G.A., Hooper D.C. Prevalence of plasmid-mediated quinolone resistance determinants over a 9-year period. Antimicrob Agents Chemother 2009, 53:639-645.
18. Kümmerer K. Pharmaceuticals in the environment. Sources, fate, effects and risks 2001, Springer, Berlin, Heidelberg. K. Kümmerer (Ed.).
19. Kümmerer K. Antibiotics in the aquatic environment - a review - Part I. Chemosphere 2009, 75:417-434.
20. Lautenbach E., Strom B.L., Nachamkin I., Bilker W.B., Marr A.M., Larosa L.A., et al. Longitudinal trends in fluoroquinolone resistance among Enterobacteriaceae isolates from inpatients and outpatients, 1989-2000: differences in the emergence and epidemiology of resistance across organisms. Clin Infect Dis 2004, 38:655-662.
21. Lee H.B., Peart T.E., Svoboda M.L. Determination of ofloxacin, norfloxacin, and ciprofloxacin in sewage by selective solid-phase extraction, liquid chromatography with fluorescence detection, and liquid chromatography-tandem mass spectrometry. J Chromatogr A 2007, 1139:45-52.
22. Literak I., Dolejska M., Janoszowska D., Hrusakova J., Meissner W., Rzyska H., et al. Antibiotic-resistant Escherichia coli bacteria, including strains with genes encoding the extended-spectrum beta-lactamase and QnrS, in waterbirds on the Baltic Sea Coast of Poland. Appl Environ Microbiol 2010, 76:8126-8134.
23. Lunn A.D., Fàbrega A., Sánchez-Céspedes J., Vila J. Prevalence of mechanisms decreasing quinolone-susceptibility among Salmonella spp. clinical isolates. Int Microbiol 2010, 13:15-20.
24. Marquardt D. You should standardize the predictor variables in your regression models. J Am Stat Assoc 1980, 75:87-91.
25. Martinez J.L. Environmental pollution by antibiotics and by antibiotic resistance determinants. Environ Pollut 2009, 157:2893-2902.
26. Martínez-Martínez L., Pascual A., Jacoby G.A. Quinolone resistance from a transferable plasmid. Lancet 1998, 351:797-799.
27. McCulloch C.E., Neuhaus J.M. Generalized linear mixed models. Encyclopedia of biostatistics 2005, John Wiley & Sons Ltd., New York. Second edition.
28. Ministry of Agriculture, Forestry and Fisheries, Japan Animal Products Safety Division, Food Safety and Consumer Affair Bureau. About risk control of fluoroquinolones that apply to cattle and swine. Letter of Notice dated 25 June 2012, [in Japanese].
29. Morgan-Linnell S.K., Zechiedrich L. Contributions of the combined effects of topoisomerase mutations toward fluoroquinolone resistance in Escherichia coli. Antimicrob Agents Chemother 2007, 51:4205-4208.
30. Morgan-Linnell S.K., Becnel Boyd L., Steffen D., Zechiedrich L. Mechanisms accounting for fluoroquinolone resistance in Escherichia coli clinical isolates. Antimicrob Agents Chemother 2009, 53:235-241.
31. Park C.H., Robicsek A., Jacoby G.A., Sahm D., Hooper D.C. Prevalence in the United States of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme. Antimicrob Agents Chemother 2005, 50:3953-3955.
32. Picão R.C., Poirel L., Demarta A., Silva C.S., Corvaglia A.R., Petrini O., et al. Plasmid-mediated quinolone resistance in Aeromonas allosaccharophila recovered from a Swiss lake. J Antimicrob Chemother 2008, 62:948-950.
33. R Development Team A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0, URL 2010, http://www.R-project.org.
34. Robicsek A., Jacoby G.A., Hooper D.C. The worldwide emergence of plasmid-mediated quinolone resistance. Lancet Infect Dis 2006, 6:629-640.
35. Rodríguez-Martínez J.M., Cano M.E., Velasco C., Martínez-Martínez L., Pascual A. Plasmid-mediated quinolone resistance: an update. J Infect Chemother 2011, 17:149-182.
36. Sorlozano A., Gutierrez J., Jimenez A., de Dios Luna J., Martínez J.L. Contribution of a new mutation in parE to quinolone resistance in extended-spectrum-beta-lactamase-producing Escherichia coli isolates. J Clin Microbiol 2007, 45:2740-2742.
37. Spongberg A.L., Witter J.D. Pharmaceutical compounds in the wastewater process stream in Northwest Ohio. Sci Total Environ 2008, 397:148-157.
38. Statistics Bureau, Ministry of Internal Affairs and Communications, Japan Statistics of stockbreeding and population survey report 2012, [in Japanese].
39. Taguchi M., Kawahara R., Seto K., Inoue K., Hayashi A., Yamagata N., et al. Plasmid-mediated quinolone resistance in Salmonella isolated from patients with overseas travelers' diarrhea in Japan. Jpn J Infect Dis 2009, 62:312-314.
40. Vien L.T.M., Baker S., Thao L.T.P., Tu L.T.P., Thuy C.T., Nga T.T.T., et al. High prevalence of plasmid-mediated quinolone resistance determinants in commensal members of the Enterobacteriaceae in Ho Chi Minh City, Vietnam. J Med Microbiol 2009, 58:1585-1592.
41. Vieno N.M., Tuhkanen T., Kronberg L. Analysis of neutral and basic pharmaceuticals in sewage treatment plants and in recipient rivers using solid phase extraction and liquid chromatography-tandem mass spectrometry detection. J Chromatogr A 2006, 1134:101-111.
42. Vieno N., Tuhkanen T., Kronberg L. Elimination of pharmaceuticals in sewage treatment plants in Finland. Water Res 2007, 41:1001-1012.
43. Wang M., Tran J.H., Jacoby G.A., Zhang Y., Wang F., Hooper D.C. Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai, China. Antimicrob Agents Chemother 2003, 47:2242-2248.
44. Wu J.J., Ko W.C., Tsai S.H., Yan J.J. Prevalence of plasmid-mediated quinolone resistance determinants QnrA, QnrB, and QnrS among clinical isolates of Enterobacter cloacae in a Taiwanese hospital. Antimicrob Agents Chemother 2007, 51:1223-1227.
45. Xiao Y., Chang H., Jia A., Hu J. Trace analysis of quinolone and fluoroquinolone antibiotics from wastewaters by liquid chromatography-electrospray tandem mass spectrometry. J Chromatogr A 2008, 1214:100-108.
46. Yamamoto A., Kakutani N., Yamamoto K., Kamiura T., Miyakoda H. Steroid hormone profiles of urban and tidal rivers using LC/MS/MS equipped with electrospray ionization and atmospheric pressure photoionization sources. Environ Sci Technol 2006, 40:4132-4137.
47. Yamane K., Wachino J., Suzuki S., Arakawa Y. Plasmid-mediated qepA gene among Escherichia coli clinical isolates from Japan. Antimicrob Agents Chemother 2008, 52:1564-1566.
48. Zhang X.X., Zhang T., Fang H.H.P. Antibiotic resistance genes in water environment. Appl Microbiol Biotechnol 2009, 82:397-414.
49. Zhao J., Chen Z., Chen S., Deng Y., Liu Y., Tian W., et al. Prevalence and dissemination of oqxAB in Escherichia coli isolates from animals, farmworkers, and the environment. Antimicrob Agents Chemother 2010, 54:4219-4224.
50. Zhou T.L., Chen X.J., Zhou M.M., Zhao Y.J., Luo X.H., Bao Q.Y. Prevalence of plasmid-mediated quinolone resistance in Escherichia coli isolates in Wenzhou, Southern China, 2002-2008. Jpn J Infect Dis 2011, 64:55-57.